1. Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML. (December 2016) Authors: Tontsch-Grunt, U.; Savarese, F.; Baum, A.; Scharn, D.; Gerlach, D.; Hofmann, M.H.; Popow, J.; Schweifer, N.; Engelhardt, H.; Musa, H.; Lee, C.P.; Munzert, G.M.; Kraut, N. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗